These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17361037)

  • 1. Correlation between platelet amyloid precursor protein isoform ratio and cognition in Alzheimer's disease.
    Liu HC; Wang HC; Ko SY; Wang PN; Chi CW; Hong CJ; Lin KN; Liu TY
    J Alzheimers Dis; 2007 Mar; 11(1):77-84. PubMed ID: 17361037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet APP isoform ratios correlate with declining cognition in AD.
    Baskin F; Rosenberg RN; Iyer L; Hynan L; Cullum CM
    Neurology; 2000 May; 54(10):1907-9. PubMed ID: 10822427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.
    Jelic V; Hagman G; Yamamoto NG; Teranishi Y; Nishimura T; Winblad B; Pavlov PF
    J Alzheimers Dis; 2013; 35(2):285-95. PubMed ID: 23388171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets.
    Sarno TA; Talib LL; Joaquim HP; Bram JM; Gattaz WF; Forlenza OV
    J Alzheimers Dis; 2017; 55(4):1445-1451. PubMed ID: 27858713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The platelet amyloid precursor protein ratio as a diagnostic marker for Alzheimer's disease in Thai patients.
    Srisawat C; Junnu S; Peerapittayamongkol C; Futrakul A; Soi-ampornkul R; Senanarong V; Praditsuwan R; Assantachai P; Neungton N
    J Clin Neurosci; 2013 May; 20(5):644-8. PubMed ID: 23453155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Distinction of Amyloid-β Protein Precursor (AβPP) Ratio in Platelet Between Alzheimer's Disease Patients and Controls: A Systematic Review and Meta-Analysis.
    Shi Y; Gu L; Alsharif AA; Zhang Z
    J Alzheimers Dis; 2017; 59(3):1037-1044. PubMed ID: 28731441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease.
    Shi Y; Gu L; Wang Q; Gao L; Zhu J; Lu X; Zhou F; Zhu D; Zhang H; Xie C; Zhang Z
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):664-670. PubMed ID: 31336382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
    Barocco F; Spallazzi M; Concari L; Gardini S; Pelosi A; Caffarra P
    J Alzheimers Dis; 2017; 57(3):775-786. PubMed ID: 28304306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet tau pattern correlates with cognitive status in Alzheimer's disease.
    Farías G; Pérez P; Slachevsky A; Maccioni RB
    J Alzheimers Dis; 2012; 31(1):65-9. PubMed ID: 22495344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smell identification function as a severity and progression marker in Alzheimer's disease.
    Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
    Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological correlates of amyloid precursor protein in Alzheimer's disease.
    Thomas LD
    Int J Nurs Pract; 1996 Mar; 2(1):29-32. PubMed ID: 9305029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of plasma p3-alcα35, a major fragment of Alcadeinα by γ-secretase cleavage, in Alzheimer's disease.
    Omori C; Kaneko M; Nakajima E; Akatsu H; Waragai M; Maeda M; Morishima-Kawashima M; Saito Y; Nakaya T; Taru H; Yamamoto T; Asada T; Hata S; Suzuki T;
    J Alzheimers Dis; 2014; 39(4):861-70. PubMed ID: 24305499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.
    Padovani A; Borroni B; Colciaghi F; Pastorino L; Archetti S; Cottini E; Caimi L; Cattabeni F; Di Luca M
    Mech Ageing Dev; 2001 Nov; 122(16):1997-2004. PubMed ID: 11589917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment.
    Borroni B; Colciaghi F; Pastorino L; Pettenati C; Cottini E; Rozzini L; Monastero R; Lenzi GL; Cattabeni F; Di Luca M; Padovani A
    Arch Neurol; 2001 Mar; 58(3):442-6. PubMed ID: 11255448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H; Forsberg A; Almkvist O; Blomquist G; Larsson E; Savitcheva I; Wall A; Ringheim A; Långström B; Nordberg A
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
    Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
    Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.
    Laske C; Sopova K; Gkotsis C; Eschweiler GW; Straten G; Gawaz M; Leyhe T; Stellos K
    J Alzheimers Dis; 2010; 21(4):1263-9. PubMed ID: 21504122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease.
    Manzine PR; Barham EJ; Vale Fde A; Selistre-de-Araújo HS; Iost Pavarini SC; Cominetti MR
    J Alzheimers Dis; 2013; 36(2):253-60. PubMed ID: 23579328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
    Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M
    Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.